Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bolelli

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Bioluminescence and Chemiluminescence|July 1, 1989
Configuration and optimization of a common two-site immunoassay for human prolactin using a chemiluminescent tracer and an enzymatic tracerL Farina, S Comuzio, G Bolelli, et al.
Prostaglandins, Leukotrienes, and Medicine|September 1, 1985
Platelet aggregation and evaluation of the ratio thromboxane B2/6-keto-prostaglandin F1 alpha in the plasma of patients on long term cimetidine treatmentG Zavagli, U Taddeo, G Bolelli, et al.
Drug and Alcohol Dependence|November 1, 1981
Hormone levels in methadone-treated drug addictsS Lafisca, G Bolelli, F Franceschetti, et al.
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1985
Free and bound testosterone in male heroin addictsS Lafisca, G Bolelli, F Franceschetti, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1988
Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRHM Filicori, E Campaniello, L Michelacci, et al.
Toxicology|December 1, 1979
Heroin addiction: relationship between the plasma levels of testosterone, dihydrotestosterone, androstenedione, LH, FSH, and the plasma concentration of heroinG Bolelli, S Lafisca, C Flamigni, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 1, 1996
Reliability of serum hormones in premenopausal and postmenopausal women over a one-year periodP Muti, M Trevisan, A Micheli, et al.
Human Reproduction (Oxford, England)|May 1, 1997
Targeted drug delivery in gynaecology: the first uterine pass effectC Bulletti, D de Ziegler, C Flamigni, et al.
Cancer|June 15, 1984
Estrone sulphate plasma levels in postmenopausal women with and without endometrial cancerV M Jasonni, C Bulletti, F Franceschetti, et al.
Journal of Steroid Biochemistry|June 1, 1986
Reduced conversion of dehydroepiandrosterone into estrogens in women having hypogonadotropic hypogonadism associated with weight lossC Bulletti, V M Jasonni, G Bolelli, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Bioluminescence and Chemiluminescence|July 1, 1989
Configuration and optimization of a common two-site immunoassay for human prolactin using a chemiluminescent tracer and an enzymatic tracerL Farina, S Comuzio, G Bolelli, et al.
Prostaglandins, Leukotrienes, and Medicine|September 1, 1985
Platelet aggregation and evaluation of the ratio thromboxane B2/6-keto-prostaglandin F1 alpha in the plasma of patients on long term cimetidine treatmentG Zavagli, U Taddeo, G Bolelli, et al.
Drug and Alcohol Dependence|November 1, 1981
Hormone levels in methadone-treated drug addictsS Lafisca, G Bolelli, F Franceschetti, et al.
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1985
Free and bound testosterone in male heroin addictsS Lafisca, G Bolelli, F Franceschetti, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1988
Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRHM Filicori, E Campaniello, L Michelacci, et al.
Toxicology|December 1, 1979
Heroin addiction: relationship between the plasma levels of testosterone, dihydrotestosterone, androstenedione, LH, FSH, and the plasma concentration of heroinG Bolelli, S Lafisca, C Flamigni, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 1, 1996
Reliability of serum hormones in premenopausal and postmenopausal women over a one-year periodP Muti, M Trevisan, A Micheli, et al.
Human Reproduction (Oxford, England)|May 1, 1997
Targeted drug delivery in gynaecology: the first uterine pass effectC Bulletti, D de Ziegler, C Flamigni, et al.
Cancer|June 15, 1984
Estrone sulphate plasma levels in postmenopausal women with and without endometrial cancerV M Jasonni, C Bulletti, F Franceschetti, et al.
Journal of Steroid Biochemistry|June 1, 1986
Reduced conversion of dehydroepiandrosterone into estrogens in women having hypogonadotropic hypogonadism associated with weight lossC Bulletti, V M Jasonni, G Bolelli, et al.
Pageof 4